Geneos Wealth Management’s McCormick & Company Non-Voting MKC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63.9K Sell
1,268
-600
-32% -$29.4K ﹤0.01% 1377
2026
Q1
$94.2K Hold
1,868
– – ﹤0.01% 1194
2025
Q4
$127K Hold
1,868
– – ﹤0.01% 1076
2025
Q3
$125K Sell
1,868
-203
-10% -$14.2K ﹤0.01% 1052
2025
Q2
$157K Buy
2,071
+411
+25% +$30.8K ﹤0.01% 1088
2025
Q1
$137K Buy
1,660
+183
+12% +$14.3K ﹤0.01% 1058
2024
Q4
$113K Buy
+1,477
New +$116K ﹤0.01% 1026
2022
Q1
– Sell
-2,669
Closed -$257K – 2894
2021
Q4
$257K Buy
2,669
+27
+1% +$2.3K 0.01% 773
2021
Q3
$213K Buy
2,642
+40
+2% +$3.43K 0.01% 828
2021
Q2
$230K Sell
2,602
-232
-8% -$20.7K 0.01% 787
2021
Q1
$256K Hold
2,834
– – 0.01% 867
2020
Q4
$234K Buy
2,834
+232
+9% +$21.9K 0.01% 775
2020
Q3
$249K Sell
2,602
-34
-1% -$3.33K 0.01% 613
2020
Q2
$232K Sell
2,636
-100
-4% -$8.24K 0.01% 625
2020
Q1
$180K Hold
2,736
– – 0.01% 644
2019
Q4
$235K Hold
2,736
– – 0.01% 644
2019
Q3
$214K Sell
2,736
-778
-22% -$62.5K 0.01% 637
2019
Q2
$272K Sell
3,514
-100
-3% -$7.71K 0.02% 575
2019
Q1
$272K Buy
3,614
+100
+3% +$6.74K 0.02% 560
2018
Q4
$244K Buy
3,514
+100
+3% +$7.17K 0.02% 542
2018
Q3
$224K Buy
3,414
+318
+10% +$19.6K 0.01% 601
2018
Q2
$179K Hold
3,096
– – 0.01% 591
2018
Q1
$164K Sell
3,096
-66
-2% -$3.47K 0.01% 590
2017
Q4
$161K Buy
3,162
+100
+3% +$4.98K 0.01% 595
2017
Q3
$157K Hold
3,062
– – 0.02% 580
2017
Q2
$149K Buy
3,062
+124
+4% +$6.28K 0.02% 575
2017
Q1
$143K Hold
2,938
– – 0.01% 561
2016
Q4
$137K Hold
2,938
– – 0.02% 533
2016
Q3
$146K Hold
2,938
– – 0.02% 515
2016
Q2
$155K Hold
2,938
– – 0.02% 494
2016
Q1
$147K Buy
+2,938
New +$132K 0.02% 500

Other funds holding MKC

Geneos Wealth Management's MKC Position: Q2 2026 in Review

Geneos Wealth Management reduced its McCormick & Company Non-Voting (MKC) stake by 32% in Q2 2026, selling an estimated $29.4K and leaving 1,268 shares worth $63.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1377.

Geneos Wealth Management first reported a position in MKC in Q1 2016 and has held it in 31 quarters since. The position peaked at $272K in Q2 2019. 954 funds tracked by Wall St. Rank hold MKC as of Q2 2026.

  • Geneos Wealth Management held 1,268 shares of McCormick & Company Non-Voting worth $63.9K as of Q2 2026.
  • Geneos Wealth Management sold 600 McCormick & Company Non-Voting shares in Q2 2026, an estimated $29.4K.
  • McCormick & Company Non-Voting made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1377 holding.
  • Geneos Wealth Management first reported a position in McCormick & Company Non-Voting in Q1 2016 and has held it in 31 quarters since.
  • Geneos Wealth Management's McCormick & Company Non-Voting position peaked at $272K in Q2 2019.
  • 954 funds tracked by Wall St. Rank held McCormick & Company Non-Voting as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.